1Milas L, Kishi K, Hunter N, et al. Enhancement of tumor response to gamma - radiation by an inhibitor of cyclooxygenase -2 enzyme [J]. J Natl Cancer Instit, 1999,91 (17):1501- 1504.
2Park JS, Jun HJ, Cho MJ, et al. Radiosensitivity enhancement by combined treatment of celecoxib and gefitinib on human lung cancer cells [J]. Clin Cancer Res, 2006, 12 (16) : 4989- 4999.
3Singh NP, McCoy MT, Tice RR, et al. A simple technique for quantitation of low levels of DNA damage in individual cells [J]. Exp Cell Res, 1988,175(1 ) : 184-191.
4Nix P,Lind M,Greenman J, et al. Expression of Cox-2 protein in radioresistant laryngeal cancer [J]. Annals of Oncology, 2004,15 (5) : 797-801.
5Terakado N, Shintani S, Yano J, et al. Overexpression of cyclooxygenase-2 is associated with radioresistance in oral squamous cell carcinoma [J ]. 2004,40 (4) : 383-389.
6Furuta Y, Hunter N, Barkley T Jr, et al. Increase in radioresponse of murine tumors by treatment with indomethacin[J]. Cancer Res, 1988,48(11) :3008-3013.
7Raju U, Nakata E, Yang P, et al. In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations [J]. Int J Radiat Oncol Biol Phys,2002, 54(3) : 886-894.
8Petersen C,Petersen S, Milas L, et al. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor[J]. Clin Cancer Res,2000,6(6):2513-2520.
9Shin YK, Park J S, Kim HS, et al. Radiosensitivity enhancement by eelecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels [J]. Cancer Res, 2005,65 (20) : 9501-9509.
10Park JS, Jun HJ Cho MJ, et al. Radiosensitivity enhancement by combined treatment of celecoxib and gefitinib on human lung cancer cells [J]. Clin Cancer Res,2006,12(16):4989-4999.
